Appendix 4C - quarterly
Released
Released
Announcement PDF
Appendix 4C
Quarterly report for entities subject to Listing Rule 4.7B
Name of entity
Xref Limited
ARBN
122 404 666
Quarter ended ("current quarter")
31 March 2017
Consolidated statement of cash flows
1
Cash flows from operating activities
1.1
Receipts from customers
1.2
Payments for
Current
Year to date
quarter
(9 months)
$A'000
$A'000
1,076
2,362
(a)
research and development
(41)
(115)
(b)
product manufacturing and operating costs
(37)
(149)
(c)
advertising and marketing
(280)
(776)
(d)
leased assets
(180)
(529)
(e)
staff costs
(1,314)
(3,474)
(f)
administration and corporate costs
(294)
(1,696)
1.3
Dividends received
-
-
1.4
Interest received
9
32
1.5
Interest and other costs of finance paid
-
-
1.6
Income taxes paid
-
2
1.7
Government grants and tax incentives
-
482
1.8
Other (provide details if material)
-
-
21
(40)
(1,040)
(3,901)
- Net GST received / (paid)
1.9
Net cash from / (used in) operating activities
Xref Limited
1 of 5
Appendix 4C - 31 March 2017
2
Cash flows from investing activities
2.1
Payments to acquire
2.2
(a)
property, plant and equipment
(b)
Current
Year to date
quarter
(9 months)
$A'000
$A'000
(16)
(88)
businesses (item 10)
-
-
(c)
investments
-
-
(d)
intellectual property
-
-
(e)
other non-current assets
-
-
Proceeds from disposal of:
-
(a)
property, plant and equipment
-
-
(b)
businesses (item 10)
-
-
(c)
investments
-
-
(d)
intellectual property
-
-
(e)
other non-current assets
-
-
2.3
Cash flows from loans to other entities
1
24
2.4
Dividends received (see note 3)
-
-
2.5
Other (provide details if material) -
-
-
2.6
Net cash from / (used in) investing activities
(15)
(64)
3
Cash flows related to financing activities
3.1
Proceeds from issues of shares
-
8,000
3.2
Proceeds from issue of convertible notes
-
-
3.3
-
-
3.4
Proceeds
from
exercise
options
Transaction
costs
relatedoftoshare
issues
of shares,
convertible notes or options
-
(540)
3.5
Proceeds from borrowings
-
-
3.6
-
-
3.7
Repayment
borrowings
Transaction of
costs
related to loans and
borrowings
-
-
3.8
Dividends paid
-
-
3.9
Other (provide details if material)
3.10
Net cash from / (used in) financing activities
-
7,460
Xref Limited
2 of 5
Appendix 4C - 31 March 2017
4
4.1
Net increase (decrease) in cash and cash equivalents
for the period held
Cash and cash equivalents at beginning of
quarter /year to date at beginning of
quarter/year
Current
quarter
Year to date
(9 months)
$A'000
$A'000
6,994
2,445
(1,040)
(3,901)
(15)
(64)
Net cash from / (used in) financing activities
(item 3.10 above)
-
7,460
4.5
Effect of movement in exchange rates on cash held
3
2
4.6
Cash and cash equivalents at end of quarter
5,942
5,942
5
Reconciliation of cash and cash equivalents
at the end of the quarter (as shown in the
consolidated statement of cash flows) to the
related items in the accounts
4.2
4.3
4.4
Net cash from / (used in) operating activities
(item 1.9 above)
Net cash from / (used in) investing activities
(item 2.6 above)
5.1
Bank balances
5.2
Current
Previous
quarter
quarter
$A'000
$A'000
5,871
6,923
Call deposits
71
71
5.3
Bank overdrafts
-
-
5.4
Other (provide details)
-
-
5.5
Cash and cash equivalents at end of quarter
(should equal item 4.6 above)
5,942
6,994
Current
quarter
6
Payments to directors of the entity and
associates of the directors
6.1
Aggregate amount of payments to these parties
included in item 1.2
$A'000
6.2
Aggregate amount of cash flow from loans to
these parties included in item 2.3
6.3
Include below any explanation necessary to understand the
transactions included in items 6.1 and 6.2
Xref Limited
146
-
3 of 5
Appendix 4C - 31 March 2017
7
Payments to related entities of the entity and
associates of the related entities
Current
quarter
$A'000
7.1
7.2
7.3
8
Aggregate amount of payments to these parties
included in item 1.2
105
Aggregate amount of cash flow from loans to
these parties included in item 2.3
Include below any explanation necessary to understand the
transactions included in 7.1 and 7.2
-
Financing facilities available
Add notes as necessary for an understanding of
the position.
Total facility
amount at
quarter end
Amount drawn
at quarter end
$A'000
$A'000
8.1
Loan facilities
-
-
8.2
Credit standby arrangements
-
-
8.3
8.4
Other (please specify)
Include below a description of each facility above, including the lender, interest rate and
whether it is secured or unsecured. If any additional facilities have been entered into or are
proposed to be entered into after quarter end, include details of those facilities as well.
-
9
Estimated cash outflows for next quarter
9.1
Research and Development
50
9.2
Product manufacturing and operating costs
100
9.3
Advertising and marketing
315
9.4
Leased assets
210
9.5
Staff costs
9.6
Administration and corporate costs
9.7
Other (provide details if material)
9.8
Total estimated cash outflows
Xref Limited
-
-
$A'000
1,600
420
2,695
4 of 5
Appendix 4C - 31 March 2017
10
Acquisitions and disposals of business
entities (items 2.1(b) and 2.2 (b) above
10.1
Name of entity
10.2
Place of incorporation or registration
10.3
Consideration for acquisition or disposal
10.4
Total net assets
10.5
Nature of business
Acquisitions
Disposals
n/a
n/a
Compliance statement
1
This statement has been prepared in accordance with accounting standards and policies which
comply with Listing Rule 19.11A.
2
This statement gives a true and fair view of the matters disclosed.
Sign here:
Print name: James Solomons, CFO
Date:
Xref Limited
6th April 2017
5 of 5
Appendix 4C - 31 March 2017
Share your feedback
Discover